• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

CA125 而非 NT-proBNP 可预测急性心力衰竭患者存在充血性肾内静脉血流。

CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure.

机构信息

Cardiology Department, Hospital Clínico Universitario de Valencia, INCLIVA, Departamento de Medicina, Universitat de València, Avda. Blasco Ibáñez 17, Valencia 46010, Spain.

Nephrology Department, Hospital Clínico Universitario de Valencia, INCLIVA, Departamento de Medicina, Universitat de València, Avda. Blasco Ibáñez 17, Valencia 46010, Spain.

出版信息

Eur Heart J Acute Cardiovasc Care. 2021 Jun 30;10(5):475-483. doi: 10.1093/ehjacc/zuab022.

DOI:10.1093/ehjacc/zuab022
PMID:33829233
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8245146/
Abstract

BACKGROUND

Intrarenal venous flow (IRVF) measured by Doppler ultrasound has gained interest as a potential surrogate marker of renal congestion and adverse outcomes in heart failure. In this work, we aimed to determine if antigen carbohydrate 125 (CA125) and plasma amino-terminal pro-B-type natriuretic peptide (NT-proBNP) are associated with congestive IRVF patterns (i.e., biphasic and monophasic) in acute heart failure (AHF).

METHODS AND RESULTS

We prospectively enrolled a consecutive cohort of 70 patients hospitalized for AHF. Renal Doppler ultrasound was assessed within the first 24-h of hospital admission. The mean age of the sample was 73.5 ± 12.3 years; 47.1% were female, and 42.9% exhibited heart failure with preserved ejection fraction. The median (interquartile range) for NT-proBNP and CA125 were 6149 (3604-12 330) pg/mL and 64 (37-122) U/mL, respectively. The diagnostic performance of both exposures for identifying congestive IRVF patterns was tested using the receiving operating curve (ROC). The cut-off for CA125 of 63.5 U/mL showed a sensibility and specificity of 67% and 74% and an area under the ROC curve of 0.71. After multivariate adjustment, CA125 remained non-linearly and positively associated with congestive IRVF (P-value = 0.008) and emerged as the most important covariate explaining the variability of the model (R2: 47.5%). Under the same multivariate setting, NT-proBNP did not show to be associated with congestive IRVF patterns (P-value = 0.847).

CONCLUSIONS

CA125 and not NT-proBNP is a useful marker for identifying patients with AHF and congestive IRVF patterns.

摘要

背景

通过多普勒超声测量的肾内静脉血流(IRVF)作为心力衰竭时肾脏淤血和不良结局的潜在替代标志物引起了关注。在这项工作中,我们旨在确定抗原碳水化合物 125(CA125)和血浆氨基末端 pro-B 型利钠肽(NT-proBNP)是否与充血性 IRVF 模式(即双相和单相)相关在急性心力衰竭(AHF)中。

方法和结果

我们前瞻性纳入了因 AHF 住院的连续队列的 70 名患者。在入院后的头 24 小时内评估肾脏多普勒超声。样本的平均年龄为 73.5±12.3 岁;47.1%为女性,42.9%表现为射血分数保留的心力衰竭。NT-proBNP 和 CA125 的中位数(四分位距)分别为 6149(3604-12330)pg/ml 和 64(37-122)U/ml。使用接收者操作曲线(ROC)测试了这两种暴露因素识别充血性 IRVF 模式的诊断性能。CA125 的截断值为 63.5U/ml,其敏感性和特异性分别为 67%和 74%,ROC 曲线下面积为 0.71。经过多变量调整后,CA125 与充血性 IRVF 呈非线性正相关(P 值=0.008),并且是解释模型变异性的最重要协变量(R2:47.5%)。在相同的多变量环境下,NT-proBNP 与充血性 IRVF 模式无关(P 值=0.847)。

结论

CA125 而不是 NT-proBNP 是识别 AHF 患者和充血性 IRVF 模式的有用标志物。

相似文献

1
CA125 but not NT-proBNP predicts the presence of a congestive intrarenal venous flow in patients with acute heart failure.CA125 而非 NT-proBNP 可预测急性心力衰竭患者存在充血性肾内静脉血流。
Eur Heart J Acute Cardiovasc Care. 2021 Jun 30;10(5):475-483. doi: 10.1093/ehjacc/zuab022.
2
Prognostic value of carbohydrate antigen 125 combined with N-terminal pro B-type natriuretic peptide in patients with acute heart failure.糖链抗原 125 联合氨基末端脑利钠肽前体对急性心力衰竭患者预后的评估价值。
Acta Cardiol. 2021 Feb;76(1):87-92. doi: 10.1080/00015385.2020.1769347. Epub 2020 Jun 10.
3
Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure.CA125 与 NT-proBNP 用于评估急性心力衰竭患者充血的比较。
Med Clin (Barc). 2021 Jun 25;156(12):589-594. doi: 10.1016/j.medcli.2020.05.063. Epub 2020 Sep 18.
4
CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation.在伴有严重三尖瓣反流的急性心力衰竭中,CA125的表现优于N末端B型利钠肽原。
Int J Cardiol. 2020 Jun 1;308:54-59. doi: 10.1016/j.ijcard.2020.03.027. Epub 2020 Mar 21.
5
Long-term serial kinetics of N-terminal pro B-type natriuretic peptide and carbohydrate antigen 125 for mortality risk prediction following acute heart failure.急性心力衰竭后死亡风险预测的 N 末端 B 型利钠肽原和糖类抗原 125 的长期序列动力学。
Eur Heart J Acute Cardiovasc Care. 2017 Dec;6(8):685-696. doi: 10.1177/2048872616649757. Epub 2016 May 19.
6
Prognostic value of NT-proBNP and CA125 across glomerular filtration rate categories in acute heart failure.急性心力衰竭中不同肾小球滤过率类别下NT-proBNP和CA125的预后价值
Eur J Intern Med. 2022 Jan;95:67-73. doi: 10.1016/j.ejim.2021.08.024. Epub 2021 Sep 8.
7
Carbohydrate antigen 125 combined with N-terminal pro-B-type natriuretic peptide in the prediction of acute heart failure following ST-elevation myocardial infarction.糖链抗原 125 联合氨基末端 B 型利钠肽原在预测 ST 段抬高型心肌梗死后急性心力衰竭中的价值。
Medicine (Baltimore). 2022 Dec 2;101(48):e32129. doi: 10.1097/MD.0000000000032129.
8
Carbohydrate antigen-125 and N-terminal pro-brain natriuretic peptide levels: compared in heart-failure prognostication.糖类抗原125与N末端脑钠肽前体水平:用于心力衰竭预后评估的比较
Tex Heart Inst J. 2012;39(1):30-5.
9
Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure.与急性心力衰竭患者血浆抗原糖 125 和氨基末端 pro-B 型利钠肽浓度相关的因素。
Eur Heart J Acute Cardiovasc Care. 2020 Aug;9(5):437-447. doi: 10.1177/2048872620908033. Epub 2020 Mar 4.
10
Utility of plasma CA125 as a proxy of intra-abdominal pressure in patients with acute heart failure.血浆 CA125 在急性心力衰竭患者中作为腹腔内压替代指标的效用。
Eur Heart J Acute Cardiovasc Care. 2022 Jun 22;11(6):453-460. doi: 10.1093/ehjacc/zuac046.

引用本文的文献

1
CA125 as a Potential Biomarker in Non-Malignant Serous Effusions: Diagnostic and Prognostic Considerations.CA125作为非恶性浆液性积液中的潜在生物标志物:诊断和预后考量
J Clin Med. 2025 Jun 11;14(12):4152. doi: 10.3390/jcm14124152.
2
Contemporary Perspectives on Congestion in Heart Failure: Bridging Classic Signs with Evolving Diagnostic and Therapeutic Strategies.心力衰竭中充血的当代观点:将经典体征与不断发展的诊断和治疗策略相联系
Diagnostics (Basel). 2025 Apr 24;15(9):1083. doi: 10.3390/diagnostics15091083.
3
Blood Biomarkers as a Non-Invasive Method for the Assessment of the State of the Fontan Circulation.血液生物标志物作为评估Fontan循环状态的非侵入性方法
J Clin Med. 2025 Jan 14;14(2):496. doi: 10.3390/jcm14020496.
4
Association Between Systemic Immune-Inflammation Index and CA125 in Older Women: Insights from a Cross-Sectional NHANES Study.老年女性全身免疫炎症指数与CA125之间的关联:一项横断面美国国家健康与营养检查调查研究的见解
Int J Womens Health. 2024 Nov 27;16:1981-1991. doi: 10.2147/IJWH.S492712. eCollection 2024.
5
CA125 outperforms NT-proBNP in the prediction of maximum aerobic capacity in heart failure with preserved ejection fraction and kidney dysfunction.在射血分数保留的心力衰竭合并肾功能不全患者中,CA125在预测最大有氧能力方面优于NT-proBNP。
Clin Kidney J. 2024 Jul 2;17(8):sfae199. doi: 10.1093/ckj/sfae199. eCollection 2024 Aug.
6
Congestion as a crucial factor determining albuminuria in patients with cardiorenal disease.充血作为决定心肾疾病患者蛋白尿的关键因素。
Clin Kidney J. 2024 May 15;17(6):sfae140. doi: 10.1093/ckj/sfae140. eCollection 2024 Jun.
7
MUC16: clinical targets with great potential.MUC16:极具潜力的临床靶点。
Clin Exp Med. 2024 May 17;24(1):101. doi: 10.1007/s10238-024-01365-5.
8
Carbohydrate Antigen 125 (CA 125): A Novel Biomarker in Acute Heart Failure.糖类抗原125(CA 125):急性心力衰竭中的一种新型生物标志物。
Diagnostics (Basel). 2024 Apr 10;14(8):795. doi: 10.3390/diagnostics14080795.
9
On Whether Ca-125 Is the Answer for Diagnosing Overhydration, Particularly in End-Stage Kidney Disease Patients-A Systematic Review.关于 CA-125 是否是诊断水中毒的答案,特别是在终末期肾病患者中-系统评价。
Int J Mol Sci. 2024 Feb 12;25(4):2192. doi: 10.3390/ijms25042192.
10
Kidney function changes in acute heart failure: a practical approach to interpretation and management.急性心力衰竭时的肾功能变化:解读与管理的实用方法
Clin Kidney J. 2023 Feb 20;16(10):1587-1599. doi: 10.1093/ckj/sfad031. eCollection 2023 Oct.

本文引用的文献

1
Intrarenal Venous Flow: A Distinct Cardiorenal Phenotype or Simply a Marker of Venous Congestion?肾内静脉血流:一种独特的心肾表型还是仅仅是静脉淤血的标志物?
J Card Fail. 2021 Jan;27(1):35-39. doi: 10.1016/j.cardfail.2020.12.001. Epub 2020 Dec 8.
2
The Effect of Decongestion on Intrarenal Venous Flow Patterns in Patients With Acute Heart Failure.充血消退对急性心力衰竭患者肾内静脉血流模式的影响。
J Card Fail. 2021 Jan;27(1):29-34. doi: 10.1016/j.cardfail.2020.09.003. Epub 2020 Sep 11.
3
Prognostic Impact of Changes in Intrarenal Venous Flow Pattern in Patients With Heart Failure.心力衰竭患者肾内静脉血流模式变化的预后影响
J Card Fail. 2021 Jan;27(1):20-28. doi: 10.1016/j.cardfail.2020.06.016. Epub 2020 Jul 9.
4
Congestion in heart failure: a contemporary look at physiology, diagnosis and treatment.心力衰竭中的充血:对生理学、诊断和治疗的当代观察。
Nat Rev Cardiol. 2020 Oct;17(10):641-655. doi: 10.1038/s41569-020-0379-7. Epub 2020 May 15.
5
Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis.CA125 在心力衰竭恶化中的临床作用:BIOSTAT-CHF 研究的亚组分析。
JACC Heart Fail. 2020 May;8(5):386-397. doi: 10.1016/j.jchf.2019.12.005. Epub 2020 Mar 11.
6
Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure.与急性心力衰竭患者血浆抗原糖 125 和氨基末端 pro-B 型利钠肽浓度相关的因素。
Eur Heart J Acute Cardiovasc Care. 2020 Aug;9(5):437-447. doi: 10.1177/2048872620908033. Epub 2020 Mar 4.
7
Doppler-Derived Renal Venous Stasis Index in the Prognosis of Right Heart Failure.多普勒衍生的肾静脉淤滞指数在右心衰竭预后中的应用。
J Am Heart Assoc. 2019 Nov 5;8(21):e013584. doi: 10.1161/JAHA.119.013584. Epub 2019 Oct 19.
8
The use of diuretics in heart failure with congestion - a position statement from the Heart Failure Association of the European Society of Cardiology.心力衰竭伴充血时利尿剂的应用——欧洲心脏病学会心力衰竭协会立场声明。
Eur J Heart Fail. 2019 Feb;21(2):137-155. doi: 10.1002/ejhf.1369. Epub 2019 Jan 1.
9
Alterations in Portal Vein Flow and Intrarenal Venous Flow Are Associated With Acute Kidney Injury After Cardiac Surgery: A Prospective Observational Cohort Study.术后心脏手术中发生的急性肾损伤与门静脉血流和肾内静脉血流改变有关:一项前瞻性观察队列研究。
J Am Heart Assoc. 2018 Oct 2;7(19):e009961. doi: 10.1161/JAHA.118.009961.
10
Intrarenal venous flow in cardiorenal syndrome: a shining light into the darkness.心肾综合征中肾内静脉血流:黑暗中的一束亮光。
ESC Heart Fail. 2018 Dec;5(6):1173-1175. doi: 10.1002/ehf2.12362. Epub 2018 Oct 8.